The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.

The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...

Aqtual has secured $31m in a Series B financing round to launch a rheumatoid arthritis (RA) therapy response prediction test.

ClearNote Health has secured the UK Conformity Assessed (UKCA) marking for the company's Avantect Pancreatic Cancer Test.

The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) for the treatment of atrial fibrillation (AF) within the NHS.

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

A Karolinska Institutet-led study has demonstrated that the use of an AI tool can enhance skin cancer diagnosis.

MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.

Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.